Activation and potential interactions between the arachidonic acid and L-arginine:nitric oxide pathways in glomerulonephritis

Kidney International

Volumn 53, Issue 3, 1998, Pages 540-547

  Lianos, Elias A ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Arachidonic acid; Cytotoxicity; Eicosanoids; Glomerulonephritis; Injury; L arginine; Nitric oxide; NO pathways

Indexed keywords

ARACHIDONIC ACID; ARGININE; NITRIC OXIDE;

ARACHIDONIC ACID METABOLISM; ARTICLE; CYTOTOXICITY; GLOMERULONEPHRITIS; KIDNEY BLOOD FLOW; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAT;

EID: 0031917363     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.1998.00792.x     Document Type: Article

References (65)

1. RAIJ L, BAYLIS C: Glomerular actions of nitric oxide. (Editorial Review) Kidney Int 48:20-32, 1995
2. BADR KF, LAKKIS FG: Lipoxygenase products in normal and diseased glomeruli, in Annals of New York Academy of Sciences. Cellular Generation, Transport and Effects of Eicosanoids. Biological Roles and Pharmacological Intervention (vol 744), edited by GOETZL EJ, LEWIS RP, ROLA-PLESZCZYNSKI M, New York, New York Academy of Sciences, 1994, pp 276-228
3. MONCADA S, PALMER RJ, HIGGS EA: Nitric oxide, physiology, pathophysiology and pharmacology. Pharmacol Rev 42:109-142, 1991
4. ROMERO JC, LAHERA V, SALOM MG, BIONDI ML: Role of endothelium-dependent relaxing factor nitric oxide on renal function. J Am Soc Nephrol 2:1371-1387, 1992
5. TERADA Y, TOMIDA K, NONOGUCHI H, MARUMO F: Polymerase chain reaction localization of constitutive nitric oxide synthase and soluble guanylase cyclase messenger RNA's in microdissected rat nephron segments. J Clin Invest 90:659-665, 1992
6. MOHAUPT MG, ELZIE LJ, NAHN KY, CLAPP WL, WILCOX CS, KONE BC: Differential expression and induction of mRNA's encoding two inducible nitric oxide synthases in rat kidney. Kidney Int 46:653-665, 1994
7. ZATZ R, DENUCCI G: Effects of acute nitric oxide inhibition on rat glomerular microcirculation. Am J Physiol 261:F360-F363, 1991
8. MARSDEN PA, BROCK TA, BALLERMANN BJ: Glomerular endothelial cells respond to calcium-mobilizing agonists with release of EDRF. Am J Physiol 258:F1295-F1303, 1990
9. LIANOS EA: Modulation of renal immune injury by eicosanoids. Am J Therapeutics 2:829-836, 1995
10. LIANOS EA, ANDRES G, DUNN MJ: Glomerular prostaglandin and thromboxane synthesis in rat nephrotoxic serum nephritis. Effects on renal hemodynamics. J Clin Invest 74:1439-1448, 1983
11. LIANOS EA: Synthesis of hydroxyeicosatetraenoic acids and leukotrienes in rat nephrotoxic serum glomerulonephritis: Role of antiglomerular basement membrane antibody dose, complement and neutrophils. J Clin Invest 82:427-435, 1988
12. CATTELL V, COOK HT: The nitric oxide pathway in glomerulonephritis. Curr Opin Nephrol Hypertens 4:4, 1995
13. LIANOS EA, BRESNAHAN BA, PAN C: Mesangial cell immune injury: Synthesis, origin and role of eicosanoids. J Clin Invest 88:623-631, 1991
14. CATTELL V, LARGEN P, DE HEER E, COOK TH: Nitrite synthesis in active Heymann nephritis is macrophage dependent, in Biology of Nitric Oxide (vol 2), edited by MONCADA S, MARLETTA MA, HIBBS JB, HIGGS EA, Portland, Portland Press Limited, 1992, pp 257-261
15. CATTELL V, LIANOS EA, LARGEN P, COOK HT: Glomerular NO synthase activity in mesangial cell immune injury. Exp Nephrol 1:36-40, 1993
16. TEJANI A, SULLIVAN EK, FINE RN, HARMON W, ALEXANDER S: Steady improvement in renal allograft survival among North American children: A five year appraisal by the North American Pediatric Renal Transplant Cooperative Study. Kidney Int 48:550-560, 1995
17. JANSEN A, COOK T, TAYLOR GM, RIVEROS-MORENO V, MONCADA S, CATTELL V: Induction of nitric oxide synthase in rat immune complex glomerulonephritis. Kidney Int 45:1215-1219, 1994
18. CAREY T, CRUET E, MUNGER K, SERHAN CN, BADR KF: Cyclooxygenase II (COX-II) expression and lipoxin (LX) biosynthesis in passive (NTS) and accelerated (aNTS) nephrotoxic serum nephritis in the rat: Modulation by aspirin (ASA) therapy. (abstract) J Am Soc Nephrol 6:753, 1995
19. RZYMKIEWICZ D, LEINGANG K, BAIRD N, MORRISON AR: Regulation of prostaglandin endoperoxide synthase gene expression in rat mesangial cells by interleukin-1β. Am J Physiol 266:F39-F45, 1994
20. STROEBEL M, GOPPELT-STRUEBE M: Signal transduction pathways responsible for serotonin-mediated prostaglandin G/H synthase expression in rat mesangial cells. J Biol Chem 269:22952-22957, 1994
21. KLEIN T, NUSING RM, PFEILSCHIFTER J, ULLRICH V: Selective inhibition of cyclooxygenase 2. Biochem Pharmacol 48:1605-1610, 1994
22. IGNARRO LJ: Signal transduction mechanisms involving nitric oxide. Biochem Pharmacol 41:485-490, 1991
23. NATHAN C: Nitric oxide as a secretory product of mammalian cells. FASEB J 6:3051-3064, 1992
24. KALYANARAMAN B, MASON RP, TAINER B, ELING TE: The free radical formed during the hydroperoxide-mediated deactivation of ram seminal vesicles is hemoprotein. J Biol Chem 257:4764-4768, 1982
25. SALVEMINI D, MISKO TP, MASFERRER JL, SEIBERT K, CURRIE MG, NEEDLEMAN P: Nitric oxide activates cyclooxygenase enzymes. Proc Natl Acad Sci USA 90:7240-7244, 1993
26. EGAN RW, PAXTON J, KUEHL FA JR: Mechanism of irreversible self-deactivation of prostaglandin-derived synthase. J Biol Chem 251:7329-7335, 1976
27. HAJJAR DP, LANDER HM, PEARCE SFA, UPMACIS RK, POMERANTZ KB: Nitric oxide enhances prostaglandin-H synthase-1 activity by a heme-independent mechanism: Evidence implicating nitrosothiols. J Am Chem Soc 117:3340-3346, 1995
28. SALVEMINI D, SETTLE SL, MASFERRER JL, MISKO TP, CURRIE MC, NEEDLEMAN P: Regulation of prostaglandin production by nitric oxide; an in vivo analysis. Br J Pharmacol 114:1171-1178, 1995
29. CORBETT JA, KWON G, TURK J, MCDANIEL ML: IL-1β induces the coexpression of both nitric oxide synthase and cyclooxygenase by islets of Langerhans: Activation of cyclooxygenase by nitric oxide. Biochem J 32:13767-13770, 1993
30. 2 production by vascular smooth muscle cells. Biochem Biophys Res Comm 194:420-424, 1993
31. DAVIDGE ST, BAKER PN, MCLAUGHLIN MK, ROBERTS JM: Nitric oxide produced by endothelial cells increases production of eicosanoid through activation of prostaglandin H synthase. Circ Res 77:274-283, 1995
32. RIEF DW, SIMMONS RD: Nitric oxide mediates iron release from ferritin. Arch Biochem Biophys 283:537-541, 1990
33. RUBBO H, PARTHASARATHY S, BARNES S, KIRK M, KALYANARAMAN B, FREEMAN BA: Nitric oxide inhibition of lipoxygenase-dependent liposome and low-density lipoprotein oxidation: Termination of radical chain propagation reactions and formation of nitrogen-containing oxidized lipid derivatives. Arch Biochem Biophys 324:15-25, 1995
34. MCCALL TB, BOUGHTON-SMITH RK, PALMER RMJ, WHITTEL BJR, MONCADA S: Synthesis of nitric oxide from L-arginine by neutrophils. Release and interaction with superoxide anion. Biochem J 261:293-296, 1989
35. 2 negatively modulates induction of nitric oxide synthase by interleukin-1. Proc Natl Acad Sci USA 91:12168-12172, 1994
36. 2 in glomerulonephritis. J Pharmacol Exp Ther 233:672-678, 1985
37. FERRARIO R, TAHASHI K, FOGO A, BADR KF, MUNGER KA: Consequences of acute nitric oxide synthase inhibition in experimental glomerulonephritis. J Am Soc Nephrol 4:1847-1854, 1994
38. 4 receptor antagonist. J Clin Invest 81:1702-1709, 1988
39. BRESNAHAN BA, WU S-H, FENOY FJ, ROMAN RJ, LIANOS EA: Mesangial cell immune injury: Hemodynamic role of leukocyte- and platelet-derived eicosanoids. J Clin Invest 90:2304-2312, 1992
40. KRAEMER SA, MEADE EA, DEWITT DL: Prostaglandin endoperoxide synthase gene structure: Identification of the transcriptional start site and 5′-flanking regulatory sequences. Arch Biochem Biophys 293:391-400, 1992
41. LANGENBACH R, MORHAM SG, TIANO HF, LOFTIN CD, GHANAYEM BI, CHULADA PC, MAHLER JF, LEE CA, GOULDING EH, KLUCKMAN KD, KIM HS, SMITHIES O: Prostaglandin synthase 1 gene disruption in mice reduces arachidonic acid-induced inflammation and indomethacin-induced gastric ulceration. Cell 83:483-492, 1995
42. MORHAM SG, LANGENBACH R, LOFTIN CD, TIANO HF, VOULOUMANOS N, JENNETTE JC, MAHLER JF, KLUCKMAN KD, LEDFORD A, LEE CA, SMITHIES O: Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse. Cell 83:473-482, 1995
43. HARRIS RC, MCKANNA JA, AKAI JA, JACOBSON HR, DUBOIS RN, BRYER MD: Cyclooxygenase-2 is associated with the macula densa of rat kidney and increases with salt restriction. J Clin Invest 94:2504-2510, 1994
44. SANO H, HLA T, MAIER JAM, CROFFORD LJ, CASE JP, MACIAG T, WILDER RL: In vivo cyclooxygenase expression in synovial tissues of patients with rheumatoid arthritis and osteoarthritis and rats with adjuvant and streptococcal cell wall arthritis. J Clin Invest 89:97-108, 1992
45. WINK DA, OSAWA Y, DARBYSHIRE F, JONES CR, ESHENAUR SC, NIMS RW: Inhibition of cytochrome P450 by nitric oxide and nitric oxide-releasing agents. Arch Biochem Biophys 300:115-123, 1993
46. LEPOIVRE M, FLAMAN JM, HENRY Y: Early loss of the tyrosyl radical in ribonucleotide reductase of adenocarcinoma cells producing nitric oxide. J Biol Chem 267:22994-23000, 1992
47. CLEETER MWJ, COOPER JM, DARLEY-USMAR EM, MONCADA S, SCHAPIRA HV: Reversible inhibition of cytochrome C oxidase, the terminal enzyme of the mitochrondrial respiratory chain, by nitric oxide. FEBS Lett 345:50-54, 1994
48. ISCHIROPOULOS H, ZHU L, CHEN J, TSAI HM, MARTIN JC, SMITH CD, BECKMAN JS: Peroxynitrite-mediated tyrosine nitration is catalyzed by superoxide dismutase. J Arch Biochem Biophys 298:431-437, 1992
49. BECKMAN JS, YE YZ, ANDERSON P, CHEN J, ACCAVETTI MA, TARPEY MN, WHITE CR: Extensive nitration of protein tyrosines observed in human atherosclerosis detected by immunohistochemistry. Biol Chem Hoppe Seyler 375:81-88, 1994
50. MORENO JJ, PRYOR WA: Inactivation of α-1-antiprotease inhibitor by peroxynitrite. Chem Res Toxicol 5:425-531, 1992
51. BAUER M, BECKMAN JS, BRIDGES R, MATLON S: Peroxynitrite inhibits sodium transport in rat colonic membrane vessicles. Biochem Biophys Acta 1104:84-87, 1992
52. RADI R, RODRIGUEZ M, CASTRO L, TELLERI R: Inhibition of mitochondrial electron transport by peroxynitrite. J Arch Biochem Biophys 308:89-95, 1994
53. GRAHAM A, HOGG N, KALYANARAMAN B, O'LEARY V, DARLEY-USMAR V, MONCADA S: Peroxynitrite modification of low-density lipoprotein leads to recognition by the macrophage scavenger receptor. FEBS Lett 330:181-185, 1993
54. WADDINGTON S, COOK HT, REAVELEY D, JANSEN A, CATTELL V: L-arginine depletion inhibits glomerular nitric oxide synthesis and exacerbates rat nephrotoxic nephritis. Kidney Int 49:1090-1096, 1996
55. G-monomethyl-L-arginine. J Exp Med 179:651-660, 1994
56. LANCASTER JR: Stimulation of the diffusion and reaction of endogenously produced nitric oxide. Proc Natl Acad Sci USA 91:8137-8141, 1994
57. CONNOR J, MANNING PT, SETTLE SL, MOORE WM, JEROME GM, WEBBER RK, TJOENG FS, CURRIE MG: Suppression of adjuvant-induced arthritis by selective inhibition of inducible nitric oxide synthase. (abstract) Eur J Pharmacol 273:1524, 1995
58. SALVEMINI D, MANNING PT, ZWEIFEL BS, SEIBERT K, CONNOR J, CURRIE MG, NEEDLEMAN P, MASFERRER JL: Dual inhibition of nitric oxide and prostaglandin production contributes to the anti-inflammatory properties of nitric oxide synthase inhibitors. J Clin Invest 96:301-308, 1995
59. MACMICKING JD, NATHAN C, HOM G, CHARTRAIN N, FLETCHER DS, TRUMBAUER M, STEVENS K, XIE Q-W, SOKOL K, HUTCHINSON N, CHEN H, MUDGETT JS: Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase. Cell 81:641-650, 1995
60. WEINBERG JB, MISUKONIS MA, WOOD ER, SMITH GL, SHAMI PL, MASON SN, GRANGER DL: Human mononuclear phagocyte nitric oxide synthase: Evidence for induction of NOS mRNA and protein without detectable capacity for nitric oxide production. (abstract) Blood 82(Suppl 1):186a(730), 1993
61. BUKRINSKY MI, NOTTET HSLM, SCHMIDTMAYEROVA H, DUBROVSKY L, FLANAGAN CR, MULLINS ME, SIPTON SA, CENDELMAN HE: Regulation of nitric oxide synthase activity in human immunodeficiency virus type 1 (HIV-1)-infected monocytes: Implications for HIV-associated neurological disease. J Exp Med 181:735-745, 1995
62. DENNIS M: Tumor necrosis factor and granulocyte macrophage-colony stimulating factor stimulate human macrophages to restrict growth of virulent Mycobacterium avium and to kill a virulent M. avium: Killing effector mechanism depends on the generation of reactive nitrogen intermediates. J Leuk Biol 49:380-387, 1991
63. MARTIN JHJ, EDWARDS SW: Changes in mechanisms of monocyte/macrophage-mediated cytotoxicity during culture: Reactive oxygen intermediates are involved in monocyte-mediated cytotoxicity, whereas reactive nitrogen intermediates are employed by macrophages in tumor cell killing. J Immunol 150:3478-3486, 1993
64. DEMARIA R, CIFONE MG, TROTTA R, RIPPO MR, FESTUCCIA C, SANTONI A, TESTI R: Triggering of human monocyte activation through CD69, a member of the natural killer cell gene complex family of signal transducing receptors. J Exp Med 180:1999-2004, 1994
65. LIANOS EA, GUGLIELMI K, SHARMA M: Regulatory interactions between inducible nitric oxide synthase and eicosanoids in glomerular injury. Kidney Int 53:645-653, 1998.